2 top stock recommendations from Amit Bhuptani
Currently, we are also seeing that the Fibonacci golden ratio is also coming near 24,400 level. So, closing once Nifty gets above that level on the spot basis, after that we will witness some stable buying in the market.
Discom health improving gradually; NTPC, Power Grid, PFC top picks: Nikhil Nigania
Power demand growth is expected to be lower in the near term due to milder weather and a high base from last year. However, medium to long-term demand is projected to grow at 6-7%. Coal availability is strong, and the government is ensuring adequate power supply, but evening peak demand remains a challenge.
Nifty up by 10% from April low. What should mutual fund investors do?
Nifty has surged 10% from its April low, reaching 24,461, prompting experts to advise caution on lumpsum investments due to expected volatility. SIPs remain the preferred route for long-term investors, while staggered allocations via STPs are suggested for those with funds. Auto, international, and tech sector funds have shown double-digit gains since April, driven by […]
Earnings to be better in cement and steel sectors in medium term: Pankaj Pandey
Pankaj Pandey suggests that while Q4 earnings were subdued, FY26 looks promising, particularly for the commodity sector. Cement and steel are highlighted as potential outperformers due to expected earnings improvements and price increases. He also notes the positive impact of declining crude oil prices on OMCs and other user industries, emphasizing the structural benefits for […]
ETMarkets PMS Talk: Karan Aggarwal on India’s 10-year wealth themes – Banks, infra & financial inclusion to lead
From the tactical success of the Elever FactorShields Fund, which delivered 20% returns in FY25, to sharp views on the US-led macro shifts and sector rotation strategies, Aggarwal outlines how investors can align portfolios for stability and long-term alpha. Edited Excerpts –
Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Pharma’s innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting heavily pre-treated RRMM patients. The tri-specific antibody showed high response rates and a favorable safety profile in early trials. Complete results will be presented at ASCO 2025. The stock rose 2.2% on Monday, with analysts maintaining a ‘Buy’ […]
DCM Shriram shares rally over 10% after Q4 profit jumps 52% YoY to Rs 179 crore
DCM Shriram’s shares surged by 10.5% following a robust Q4 FY25 performance, with net profit soaring 51.9% to Rs 178.9 crore. Revenue climbed 19.9% to Rs 2,876.7 crore, driven by strong segment results and improved EBITDA margins of 14.1%. The board has proposed a final dividend of Rs 3.40 per share.
Positive Breakout: These 9 stocks cross above their 200 DMAs
In the Nifty200 pack, nine stocks’ close prices crossed above their 200 DMA (Daily Moving Averages) on May 05, according to stockedge.com’s technical scan data. The 200-day DMA is used as a key indicator by traders for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day […]
Iware Supplychain shares to list today. GMP suggests muted listing ahead
Iware Supplychain Services is set to debut on the BSE SME platform with modest expectations, indicated by a grey market premium of Rs 2. The IPO, aiming to raise Rs 27 crore, was subscribed 3 times. The company, an integrated logistics player with warehousing and transportation services, reported revenues of Rs 85.82 crore and a […]
Q4 results today: Paytm, BSE among 53 companies to announce earnings on Tuesday
The fourth quarter earnings season is gaining traction, with several companies, including Bank of Baroda, Paytm, BSE, and HPCL, set to announce their results on Tuesday. Paytm’s Q4FY25 earnings are keenly anticipated, with some brokerages projecting a profit, while others foresee a reduced loss.